Principia Biopharma, Inc.. (PRNB) NASDAQ

$100.05 0 (0.00%)

Market Cap: $3.32B

As of 09/25/20 12:00 AM EDT. Market closed.

(PRNB)

Principia Biopharma, Inc.. (PRNB) NASDAQ

$100.05 0 (0.00%)

Market Cap: $3.32B

As of 09/25/20 12:00 AM EDT. Market closed.

Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, ... read more

Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Martin Babler
Full Time Employees
103
CEO Compensation (Base)
$447,128
CEO Compensation (Total)
$2.32M
URL
Address
220 East Grand Avenue, CA, South San Francisco, 94080.
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Martin Babler
Full Time Employees
103
CEO Compensation (Base)
$447,128
CEO Compensation (Total)
$2.32M
Address
220 East Grand Avenue, CA, South San Francisco, 94080.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$100.05
Days Range
$0 - $0
52 week range
$25.35 - $101.89
Volume
0
Avg. Volume (30 days)
2,469,813
Market Cap
$3.32B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,208,500
Open
$0
Previous Close
$100.05
Days Range
$0 - $0
52 week range
$25.35 - $101.89
Volume
0
Avg. Volume (30 days)
2,469,813
Market Cap
$3.32B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,208,500

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PRINCIPIA BIOPHARMA, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
George Simeon Director Sep 28, 2020 Option Exercise $100.00 2,982,855 298,285,500 0 Sep 28, 2020, 05:27 PM
Becker Daniel J. Director Sep 28, 2020 Option Exercise $100.00 667,600 66,760,000 0 Sep 28, 2020, 05:24 PM
Wolff Stefani Chief Development Officer Sep 28, 2020 Option Exercise $100.00 13,592 1,359,200 0 Sep 28, 2020, 05:19 PM
Thomas Dolca Chief Medical Officer Sep 28, 2020 Option Exercise $100.00 2,207 220,700 0 Sep 28, 2020, 05:16 PM
Hardiman Roy C. Chief Business Officer Sep 28, 2020 Option Exercise $100.00 1,916 191,600 0 Sep 28, 2020, 05:14 PM
Hardiman Roy C. Chief Business Officer Sep 28, 2020 Option Exercise $100.00 117,761 11,776,100 0 Sep 28, 2020, 05:14 PM
CHAI CHRISTOPHER Y Chief Financial Officer Sep 28, 2020 Option Exercise $100.00 3,302 330,200 0 Sep 28, 2020, 05:11 PM
CHAI CHRISTOPHER Y Chief Financial Officer Sep 28, 2020 Option Exercise $100.00 3,799 379,900 0 Sep 28, 2020, 05:11 PM
Goldstein David M Chief Scientific Officer Sep 28, 2020 Option Exercise $100.00 31,826 3,182,600 0 Sep 28, 2020, 05:08 PM
Babler Martin President, CEO Sep 28, 2020 Option Exercise $100.00 57,534 5,753,400 0 Sep 28, 2020, 05:07 PM
Babler Martin President, CEO Sep 28, 2020 Option Exercise $100.00 1,023 102,300 0 Sep 28, 2020, 05:07 PM
Hardiman Roy C. Chief Business Officer Sep 18, 2020 Option Exercise $5.86 5,000 29,321 122,761 Sep 22, 2020, 08:02 PM
Hardiman Roy C. Chief Business Officer Sep 18, 2020 Sale $99.98 5,000 499,917 117,761 Sep 22, 2020, 08:02 PM
Thomas Dolca Chief Medical Officer Aug 18, 2020 Option Exercise $23.77 15,000 356,550 16,826 Aug 20, 2020, 08:17 PM
Thomas Dolca Chief Medical Officer Aug 18, 2020 Sale $100.00 15,000 1,500,000 1,826 Aug 20, 2020, 08:17 PM
CHAI CHRISTOPHER Y Chief Financial Officer Aug 18, 2020 Option Exercise $3.00 7,500 22,483 11,039 Aug 20, 2020, 08:01 PM
CHAI CHRISTOPHER Y Chief Financial Officer Aug 18, 2020 Sale $99.37 7,500 745,240 3,539 Aug 20, 2020, 08:01 PM
Goldstein David M Chief Scientific Officer Aug 10, 2020 Option Exercise $3.11 6,000 18,632 37,739 Aug 12, 2020, 08:01 PM
Goldstein David M Chief Scientific Officer Aug 10, 2020 Sale $88.61 6,000 531,665 36,881 Aug 12, 2020, 08:01 PM
Thomas Dolca Chief Medical Officer Jul 15, 2020 Option Exercise $23.77 15,000 356,550 16,826 Jul 17, 2020, 08:01 PM
Thomas Dolca Chief Medical Officer Jul 15, 2020 Sale $80.07 15,000 1,201,069 1,826 Jul 17, 2020, 08:01 PM
Colowick Alan Director Jul 01, 2020 Option Exercise $4.54 7,500 34,065 7,500 Jul 02, 2020, 08:48 PM
Colowick Alan Director Jul 01, 2020 Sale $60.00 7,500 450,000 0 Jul 02, 2020, 08:48 PM
Babler Martin President, CEO Jun 23, 2020 Option Exercise $3.00 15,000 44,965 15,810 Jun 25, 2020, 08:07 PM
Babler Martin President, CEO Jun 23, 2020 Sale $61.86 15,000 927,889 15,295 Jun 25, 2020, 08:07 PM
Wolff Stefani Chief Development Officer Jun 15, 2020 Sale $60.75 5,504 334,385 24,200 Jun 17, 2020, 09:52 PM
Wolff Stefani Chief Development Officer Mar 16, 2020 Sale $46.15 5,504 254,031 28,350 Jun 17, 2020, 09:48 PM
Wolff Stefani Chief Development Officer Dec 16, 2019 Sale $49.43 5,505 272,091 31,404 Jun 17, 2020, 09:41 PM
Hardiman Roy C. Chief Business Officer Jun 12, 2020 Option Exercise $4.72 5,000 23,618 122,761 Jun 15, 2020, 08:12 PM
Hardiman Roy C. Chief Business Officer Jun 12, 2020 Sale $61.16 5,000 305,788 121,166 Jun 15, 2020, 08:12 PM
CHAI CHRISTOPHER Y Chief Financial Officer May 19, 2020 Option Exercise $3.00 5,675 17,012 11,039 May 21, 2020, 08:01 PM
CHAI CHRISTOPHER Y Chief Financial Officer May 19, 2020 Sale $65.10 7,500 488,268 3,539 May 21, 2020, 08:01 PM
Goldstein David M Chief Scientific Officer May 07, 2020 Option Exercise $3.00 6,000 17,986 36,968 May 08, 2020, 08:05 PM
Goldstein David M Chief Scientific Officer May 07, 2020 Sale $60.16 6,000 360,941 33,687 May 08, 2020, 08:05 PM
Colowick Alan Director May 01, 2020 Option Exercise $4.54 840 3,815 840 May 05, 2020, 08:07 PM
Colowick Alan Director May 05, 2020 Option Exercise $4.54 6,660 30,250 6,660 May 05, 2020, 08:07 PM
Colowick Alan Director May 01, 2020 Sale $60.07 840 50,457 0 May 05, 2020, 08:07 PM
Colowick Alan Director May 05, 2020 Sale $60.00 6,660 399,600 0 May 05, 2020, 08:07 PM
Wolff Stefani Chief Development Officer Mar 16, 2020 Option Exercise $4.54 5,504 24,999 41,113 Mar 18, 2020, 05:08 PM
Wolff Stefani Chief Development Officer Mar 16, 2020 Sale $46.15 5,504 254,031 39,359 Mar 18, 2020, 05:08 PM
Hardiman Roy C. Chief Business Officer Mar 13, 2020 Option Exercise $4.72 5,000 23,618 121,903 Mar 17, 2020, 05:08 PM
Hardiman Roy C. Chief Business Officer Mar 13, 2020 Sale $48.56 5,000 242,816 118,184 Mar 17, 2020, 05:08 PM
Babler Martin President, CEO Mar 03, 2020 Sale $63.47 15,000 952,083 52,094 Mar 05, 2020, 05:21 PM
CHAI CHRISTOPHER Y Chief Financial Officer Feb 18, 2020 Option Exercise $3.00 2,500 7,494 12,266 Feb 20, 2020, 05:02 PM
CHAI CHRISTOPHER Y Chief Financial Officer Feb 18, 2020 Sale $65.89 7,500 494,186 9,582 Feb 20, 2020, 05:02 PM
Goldstein David Chief Scientific Officer Feb 10, 2020 Option Exercise $3.00 6,000 17,986 36,968 Feb 12, 2020, 07:03 PM
Goldstein David Chief Scientific Officer Feb 10, 2020 Sale $70.90 6,000 425,400 36,168 Feb 12, 2020, 07:03 PM
Thomas Dolca Chief Medical Officer Dec 19, 2019 Sale $60.00 495 29,700 494 Dec 20, 2019, 09:00 PM
Babler Martin President, CEO Dec 18, 2019 Sale $53.66 4,500 241,459 19,196 Dec 19, 2019, 09:06 PM
Babler Martin President, CEO Dec 17, 2019 Sale $52.96 25,000 1,323,996 73,339 Dec 19, 2019, 09:06 PM
Wolff Stefani Chief Development Officer Dec 16, 2019 Option Exercise $4.54 5,505 25,004 41,114 Dec 18, 2019, 07:09 PM
Wolff Stefani Chief Development Officer Dec 16, 2019 Sale $49.43 5,505 272,091 36,909 Dec 18, 2019, 07:09 PM
Hardiman Roy C. Chief Business Officer Dec 13, 2019 Option Exercise $4.95 5,000 24,743 125,143 Dec 13, 2019, 08:04 PM
Hardiman Roy C. Chief Business Officer Dec 13, 2019 Sale $49.41 5,000 247,034 121,762 Dec 13, 2019, 08:04 PM
Becker Daniel J. Director Nov 20, 2019 Buy $29.94 55,000 1,646,700 667,600 Nov 22, 2019, 08:07 PM
Goldstein David Chief Scientific Officer Nov 07, 2019 Option Exercise $1.88 10,000 18,815 39,819 Nov 08, 2019, 09:01 PM
Goldstein David Chief Scientific Officer Nov 07, 2019 Sale $32.39 10,000 323,914 29,819 Nov 08, 2019, 09:01 PM
Becker Daniel J. Director Oct 29, 2019 Buy $33.98 9,196 312,477 612,600 Oct 30, 2019, 04:16 PM
Becker Daniel J. Director Oct 28, 2019 Buy $33.41 68,404 2,285,549 603,404 Oct 30, 2019, 04:16 PM
GLAXOSMITHKLINE PLC Former 10% Owner Oct 18, 2019 Buy $28.00 357,142 9,999,976 2,982,855 Oct 22, 2019, 05:36 PM
George Simeon Director Oct 18, 2019 Buy $28.00 357,142 9,999,976 2,982,855 Oct 22, 2019, 04:11 PM
Becker Daniel J. Director Oct 18, 2019 Buy $28.00 535,000 14,980,000 535,000 Oct 22, 2019, 04:06 PM
New Leaf Ventures II, L.P. 10% Owner Aug 13, 2019 Sale $35.00 300,000 10,500,000 1,938,167 Aug 15, 2019, 04:47 PM
ORBIMED ADVISORS LLC 10% Owner May 21, 2019 Sale $30.25 1,000,000 30,250,000 1,605,713 May 22, 2019, 12:43 PM
Sofinnova Venture Partners VIII, L.P. 10% Owner Sep 18, 2018 Buy $17.00 270,000 4,590,000 2,038,208 Sep 20, 2018, 07:02 PM
ORBIMED ADVISORS LLC 10% Owner Sep 18, 2018 Buy $17.00 250,000 4,250,000 2,605,713 Sep 20, 2018, 06:59 PM
Becker Daniel J. Director Sep 18, 2018 Buy $17.00 270,000 4,590,000 437,537 Sep 20, 2018, 06:58 PM
New Leaf Ventures II, L.P. 10% Owner Sep 18, 2018 Buy $17.00 270,000 4,590,000 437,537 Sep 20, 2018, 06:53 PM
George Simeon Director Sep 18, 2018 Buy $17.00 270,000 4,590,000 2,625,713 Sep 20, 2018, 06:50 PM
GLAXOSMITHKLINE PLC 10% Owner Sep 18, 2018 Buy $17.00 270,000 4,590,000 2,625,713 Sep 20, 2018, 05:18 PM
AKKARAJU SRINIVAS Director Sep 18, 2018 Buy $17.00 175,000 2,975,000 383,480 Sep 20, 2018, 04:14 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
George Simeon Director 09/28/2020 298,285,500
Becker Daniel J. Director 09/28/2020 66,760,000
Wolff Stefani Chief Development Officer 09/28/2020 1,359,200
Thomas Dolca Chief Medical Officer 09/28/2020 220,700
Hardiman Roy C. Chief Business Officer 09/28/2020 191,600
Hardiman Roy C. Chief Business Officer 09/28/2020 11,776,100
CHAI CHRISTOPHER Y Chief Financial Officer 09/28/2020 330,200
CHAI CHRISTOPHER Y Chief Financial Officer 09/28/2020 379,900
Goldstein David M Chief Scientific Officer 09/28/2020 3,182,600
Babler Martin President, CEO 09/28/2020 5,753,400
Babler Martin President, CEO 09/28/2020 102,300
Hardiman Roy C. Chief Business Officer 09/18/2020 29,321
Hardiman Roy C. Chief Business Officer 09/18/2020 499,917
Thomas Dolca Chief Medical Officer 08/18/2020 356,550
Thomas Dolca Chief Medical Officer 08/18/2020 1,500,000
CHAI CHRISTOPHER Y Chief Financial Officer 08/18/2020 22,483
CHAI CHRISTOPHER Y Chief Financial Officer 08/18/2020 745,240
Goldstein David M Chief Scientific Officer 08/10/2020 18,632
Goldstein David M Chief Scientific Officer 08/10/2020 531,665
Thomas Dolca Chief Medical Officer 07/15/2020 356,550
Thomas Dolca Chief Medical Officer 07/15/2020 1,201,069
Colowick Alan Director 07/01/2020 34,065
Colowick Alan Director 07/01/2020 450,000
Babler Martin President, CEO 06/23/2020 44,965
Babler Martin President, CEO 06/23/2020 927,889
Wolff Stefani Chief Development Officer 06/15/2020 334,385
Wolff Stefani Chief Development Officer 03/16/2020 254,031
Wolff Stefani Chief Development Officer 12/16/2019 272,091
Hardiman Roy C. Chief Business Officer 06/12/2020 23,618
Hardiman Roy C. Chief Business Officer 06/12/2020 305,788
CHAI CHRISTOPHER Y Chief Financial Officer 05/19/2020 17,012
CHAI CHRISTOPHER Y Chief Financial Officer 05/19/2020 488,268
Goldstein David M Chief Scientific Officer 05/07/2020 17,986
Goldstein David M Chief Scientific Officer 05/07/2020 360,941
Colowick Alan Director 05/01/2020 3,815
Colowick Alan Director 05/05/2020 30,250
Colowick Alan Director 05/01/2020 50,457
Colowick Alan Director 05/05/2020 399,600
Wolff Stefani Chief Development Officer 03/16/2020 24,999
Wolff Stefani Chief Development Officer 03/16/2020 254,031
Hardiman Roy C. Chief Business Officer 03/13/2020 23,618
Hardiman Roy C. Chief Business Officer 03/13/2020 242,816
Babler Martin President, CEO 03/03/2020 952,083
CHAI CHRISTOPHER Y Chief Financial Officer 02/18/2020 7,494
CHAI CHRISTOPHER Y Chief Financial Officer 02/18/2020 494,186
Goldstein David Chief Scientific Officer 02/10/2020 17,986
Goldstein David Chief Scientific Officer 02/10/2020 425,400
Thomas Dolca Chief Medical Officer 12/19/2019 29,700
Babler Martin President, CEO 12/18/2019 241,459
Babler Martin President, CEO 12/17/2019 1,323,996
Wolff Stefani Chief Development Officer 12/16/2019 25,004
Wolff Stefani Chief Development Officer 12/16/2019 272,091
Hardiman Roy C. Chief Business Officer 12/13/2019 24,743
Hardiman Roy C. Chief Business Officer 12/13/2019 247,034
Becker Daniel J. Director 11/20/2019 1,646,700
Goldstein David Chief Scientific Officer 11/07/2019 18,815
Goldstein David Chief Scientific Officer 11/07/2019 323,914
Becker Daniel J. Director 10/29/2019 312,477
Becker Daniel J. Director 10/28/2019 2,285,549
GLAXOSMITHKLINE PLC Former 10% Owner 10/18/2019 9,999,976
George Simeon Director 10/18/2019 9,999,976
Becker Daniel J. Director 10/18/2019 14,980,000
New Leaf Ventures II, L.P. 10% Owner 08/13/2019 10,500,000
ORBIMED ADVISORS LLC 10% Owner 05/21/2019 30,250,000
Sofinnova Venture Partners VIII, L.P. 10% Owner 09/18/2018 4,590,000
ORBIMED ADVISORS LLC 10% Owner 09/18/2018 4,250,000
Becker Daniel J. Director 09/18/2018 4,590,000
New Leaf Ventures II, L.P. 10% Owner 09/18/2018 4,590,000
George Simeon Director 09/18/2018 4,590,000
GLAXOSMITHKLINE PLC 10% Owner 09/18/2018 4,590,000
AKKARAJU SRINIVAS Director 09/18/2018 2,975,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2020
03/31/2020
0.14%
1Q
06/30/2020
12/31/2019
28.17%
2Q
06/30/2020
09/30/2019
38.03%
3Q
06/30/2020
03/31/2019
38.44%
5Q
Load More

Period of Report: 06/30/2020

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2020
0.14%
1Q
12/31/2019
28.17%
2Q
09/30/2019
38.03%
3Q
03/31/2019
38.44%
5Q
Load More